| Autor: |
Sin DD; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; St Paul's Hospital, Vancouver, BC, Canada., Chalmers JD; University of Dundee, Dundee, UK j.chalmers@dundee.ac.uk.; Ninewells Hospital, Dundee, UK. |
| Jazyk: |
angličtina |
| Zdroj: |
The European respiratory journal [Eur Respir J] 2024 Jan 04; Vol. 63 (1). Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024). |
| DOI: |
10.1183/13993003.02215-2023 |
| Abstrakt: |
Competing Interests: Conflicts of interest: J.D. Chalmers has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Grifols, Novartis, Insmed and Trudell; and received consultancy or speaker fees from Antabio, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Janssen, Novartis, Pfizer, Trudell and Zambon. D.D. Sin has received a stipend for giving talks on COPD from AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
